FIELD: medicine, clinical virology.
SUBSTANCE: method involves assay of antibodies raised against some antigen sites of two surface proteins (E1 and E2) by using the following 5 synthetic peptides as antigens: 1) NH2-SGHRMAWDMMMNWSP-CONH2; 2) NH2-STLTSLPTPGASG-CONH2; 3) NH2-RPYAWHYAPRPAGIVPASQV-CONH2; 4) NH-TTDRIFGAPTYSWGENETDVL-CONH2; 5) NH2-TWIMNSTGFTKTAGGPPANIGGVGNNT-CONH2. The favorable finish of disease is prognosticated by detection of antibodies for the first 3-4 weeks of disease. The advantage of the invention involves the prognosis for the disease finish in the early stage of disease. Invention can be used in clinics of infectious diseases for aims of early prognosis of acute hepatitis C finish.
EFFECT: improved method for prognosis of hepatitis C.
6 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETECTION OF ANTIBODY TO HEPATITIS VIRUS C NUCLEAR PROTEIN | 1997 |
|
RU2133622C1 |
| TEST SYSTEM FOR DETECTING ANTIBODIES TO NUCLEAR PROTEIN OF HEPATITIS C OF IGM CLASS | 1997 |
|
RU2142134C1 |
| IMMUNOSORBENT FOR DETECTION OF ANTIBODY TO HEPATITIS C VIRUS NUCLEAR PROTEIN IN BLOOD SERUM | 1997 |
|
RU2138286C1 |
| COMPOSITION BASED ON SYNTHETIC PEPTIDES AND LIPIDS FOR C HEPATITIS VACCINE | 2015 |
|
RU2675108C2 |
| MONOCLONAL ANTIBODY IMMUNOREACTIVE WITH NUCLEOCAPSID (CORE) PROTEIN OF C-4G5 HEPATITIS VIRUS, METHOD OF DIAGNOSTICS OF HEPATITIS C VIRAL (HCV) INFECTION, AND COMBINATION OF MONOCLONAL ANTIBODIES FOR ITS IMPLEMENTATION | 2006 |
|
RU2329303C2 |
| RECOMBINANT MODIFIED VIRUS OF VACCINE ANKARA ABLE TO EXPRESS HEPATITIS C VIRUS STRUCTURAL ANTIGENS | 2002 |
|
RU2270860C2 |
| METHOD FOR MAKING LOW-TITRE SERUM PANEL FOR QUALITY CONTROL OF TEST SYSTEMS AND IMMUNOBLOTS USED FOR DIAGNOSING ANTIBODIES TO VARIOUS CVH SUBTYPES | 2009 |
|
RU2408024C1 |
| ANTIGEN SET FOR SEPARATE DETECTION OF ANTIBODIES TO STRUCTURAL AND NON-STRUCTURAL PROTEINS OF HEPATITIS C VIRUS | 2007 |
|
RU2370776C2 |
| OLIGOMERIC PARTICLE INDUCING IMMUNITY AGAINST HEPATITIS C VIRUS, METHOD FOR PREPARING OLIGOMERIC PARTICLE, COMPOSITION, SPECIFIC ANTIBODY, SET (VARIANTS), IMMUNOLOGICAL ANALYSIS AND VACCINE AGAINST HEPATITIS C VIRUS | 1999 |
|
RU2247729C2 |
| RECOMBINANT PROTEIN CONTAINING ANTIGEN-SIGNIFICANT FRAGMENTS OF HEPATITIS E VIRUS PROTEINS, USED IN TEST SYSTEMS FOR HEPATITIS E SERODIAGNOSIS (EMBODIMENTS) | 2017 |
|
RU2711907C2 |
